| 产品详情 |
| Edit |   |
| Product Name | 17-DMAG, Hydrochloride Salt |
| Description | 17-DMAG (Alvespimycin, KOS-1022, NSC 707545) is a potent HSP90 inhibitor with IC50 of 62 nM. A Phase I study of 17-DMAG in treating patients with an advanced solid tumor or lymphoma has been completed.A Phase I study of the combination of intravenous 17-DMAG, Trastuzumab with or without Paclitaxel in patients with advanced solid tumor malignancies or Her2 positive metastatic breast cancer who have previously failed frastuzumab therapy has been completed. 17-DMAG is a synthetic derivative of the antibiotic Geldanamycin with lower hepatotoxicity than the parent antibiotic and higher potency and availability than the similar derivative 17-AAG. MW: 653.21 g/mol. Purity >99% pure |
| Size | 25 mg, 100 mg, 250 mg, 500 mg, 1 g, 2 g, 5 g, 10 g |
| Concentration | n/a |
| Applications | n/a |
| Other Names | Alvespimycin hydrochloride, 17-DMAG, NSC 707545, Alvespimycin HCl, 17DMAG |
| Gene, Accession, CAS # | CAS: 467214-21-7 |
| Catalog # | orb61016 |
| Price | |
| Order / More Info | 17-DMAG, Hydrochloride Salt from BIORBYT LTD. |
| Product Specific References | n/a |
| 产品资料 |
|
|